Podcasts about ozempic

Welcome to Ozempic Weightloss Unlocked, where we dive into the latest news on Ozempic, from medical breakthroughs to lifestyle impacts.Ozempic, a glucagon-like peptide one receptor agonist, mimics a hormone that curbs appetite, slows stomach emptying, and boosts insulin, leading to significant weight loss. Studies from the University of Texas at Arlington show it helps people shed up to twenty percent of body weight over months by suppressing hunger.Exciting pill option now available. Reuters reports the Food and Drug Administration approved Novo Nordisk's twenty-five milligram oral semaglutide pill, branded Wegovy, for chronic weight management in adults with obesity or overweight plus related conditions. In trials from Healthbanks, daily semaglutide pills led to nearly fourteen percent body weight loss over sixty-four weeks, versus two percent on placebo. AOL notes oral Wegovy users lost thirteen point six percent over fifteen months, cutting sick days in half.Beyond weight, new benefits emerge. University of Colorado Anschutz research highlights GLP-one agonists like Ozempic easing knee osteoarthritis pain and improving function in obese patients, per a Denmark and Canada trial.American Cancer Society explains most loss happens in year one, slowing after, with some regain upon stopping, so long-term use with diet and exercise is key. Older adults often quit early, per New York Times via American Medical Association, due to muscle loss or shortages, regaining weight.Pair with healthy habits for best results, listeners. Consult your doctor.Thanks for tuning in, listeners. Subscribe for more updates. This has been a Quiet Please production, for more check out quietplease.ai. Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

This week, The Daily is revisiting some of our favorite episodes of the year and checking in on what has happened in the time since.In the past few years, GLP-1 weight-loss drugs like Ozempic and Zepbound have been radically reshaping the people's lives, changing appetites and health.But the drugs also have the power to affect other parts of consumers' lives, including their romantic relationships.Lisa Miller, who writes about health for The New York Times, tells the story of how these drugs upended one couple's marriage.Guest: Lisa Miller, a domestic correspondent for the Well section who writes about personal and cultural approaches to physical and mental health.Background reading: Listen to the original version of the episode here.Weight-loss drugs have lesser-known side effects on relationships.Photo: Katherine Wolkoff for The New York TimesFor more information on today's episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

This episode - brought to you by our incredible sponsors: RIDGE - Take advantage of Ridge's Biggest Sale of the Year and GET UP TO 47% Off by going to ⁠https://www.Ridge.com/HARDFACTOR⁠ #Ridgepod DaftKings - Download the DraftKings Casino app, sign up with code HARDFACTOR, and spin your favorite slots! The Crown is Yours - Gambling problem? Call one eight hundred GAMBLER Lucy - Level up your nicotine routine with Lucy. Go to Lucy.co/HARDFACTOR and use promo code (HARDFACTOR) to get 20% off your first order. Lucy has a 30-day refund policy if you change your mind Timestamps: 00:00:00 Story teases 00:01:20 Remembering the woman whose face was ripped off by a chimpanzee 00:05:00 Pat's losing weight 00:06:15 Good penis angles 00:08:20 Update on the nighttime erection monitor device 00:17:30 Christmas plans 00:22:15 Ozempic vagina 00:24:55 What would you do if you won the Powerball? 00:30:30 Nicki Minaj at Turning Point and much more... Thank you for listening!! Go to Patreon.com/hardfactor to join our community, get access to bonus pods, discord chat and much more - but Most Importantly: HADFD!! Hosts: Pat Cassidy | IG | XMark Borghi | IG | XWes Shephard | IG | XWill Smith | IG | X Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Mike explains breaks down the timeline and phases of perimenopause. He also goes into detail about what labs you should run and how to optimize your plan to feel your best during this phase of life.------------------------------------------------Click here to apply for coaching!For some amazing resources and to be a part of a badass community, join our FB group HEREThe personality assessment is now available online! Click here to take the assessment and find out what your personality tells us about the way you should be training and eating.Take the assessment here!To learn more about Neurotyping, visit www.neurotypetraining.comFollow Mike on IG at @coach_mike_millner

On this hard-hitting episode of Start Today, I bring back Jay Campbell to expose what's really happening behind the scenes with peptides, GLP-1 drugs, and Big Pharma's quiet push to shut down affordable optimization. We break down why January could change everything—from access restrictions to rising costs—and what men need to know now before the window closes.  We also get into why Ozempic is already obsolete, what's coming next with GLP-3s, how peptides actually work, and the three non-negotiables for men who want strength, clarity, and longevity. No hype. No shortcuts. Just real talk you won't hear from your doctor.  

In this episode of the Smarter Not Harder Podcast, Cynthia Thurlow joins Dr. Scott Sherr for a wide-ranging and refreshingly honest conversation about fasting, female hormones, GLP-1s, and navigating midlife as a high-performing woman. With clarity and nuance, Cynthia breaks down what works — and what backfires — when it comes to metabolic health for women over 35. Join us as we delve into: • Why intermittent fasting isn't a one-size-fits-all solution • How hormone shifts change the fasting game for women • What GLP-1s like Ozempic and Wegovy really do — and don't do • How to stay metabolically flexible through perimenopause This episode is for you if: • You're a woman over 35 trying to fast smarter, not harder • You're curious about GLP-1s but want balanced, science-based insight • You've hit a metabolic wall and need smarter strategies • You want practical, hormone-informed tools for fat loss and focus You can also find this episode on… YouTube: https://youtu.be/5oVPHVbyUcw Find more from Cynthia Thurlow: Website: https://www.cynthiathurlow.com Instagram: https://www.instagram.com/cynthia_thurlow_ Find more from Smarter Not Harder: Website: https://troscriptions.com/blogs/podcast?utm_source=youtube&utm_medium=video&utm_campaign=snh_podcast_guest_episode_2025_10&utm_content=podcast_asset Instagram: https://www.instagram.com/troscriptions Get 10% Off your purchase of Clinical Metabolomics Module by using PODCAST10 at https://www.homehope.org Get 10% Off your Troscriptions purchase by using POD10 at https://www.troscriptions.com Get daily content from the hosts of Smarter Not Harder by following @troscriptions on Instagram.

It's a family affair as we make Jamie join us for Avatar: Fire and Ash and ponder the following: Who is responsible for making Tulkun jewelry? Is there Ozempic on Pandora? Which of his own filmography will James Cameron reference next? (Hoping itsTrue Lies).Find us at:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ www.werewatchingwhat.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠,⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠instagram.com/werewatchingwhat⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/thedhk⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠instagram.com/thedhk⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠facebook.com/thedhkmovies⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠tiktok.com/werewatchingwhat⁠⁠⁠⁠⁠⁠⁠

The Trump administration announces it will begin garnishing wages for unpaid student loans, and Joe Pags says it's the right move — while also making his case that student loans should be low-interest or interest-free. Callers weigh in, and the debate gets lively and revealing. Then Jesse Lopez joins the show for a must-hear medical deep dive. Dr. Lopez explains what it really means when the immune system is compromised, why he's critical of continued COVID booster shots, and what people should understand about GLP-1 drugs, including the much-talked-about “Ozempic face.” He breaks down how the immune system responds to medications and what patients aren't being told. Expert insight, real questions, and information you need to hear. Learn more about your ad choices. Visit megaphone.fm/adchoices

Most conversations about longevity focus on tactics. This episode breaks down the biology underneath them. You'll hear a systems level analysis of how insulin signaling, mTOR, mitochondrial function, inflammation, and nutrient sensing interact to determine biological age, disease risk, and long term human performance. This is not surface level biohacking. It is a deep dive into the mechanisms that actually control aging, metabolism, muscle preservation, and brain optimization, and why most anti aging strategies fail when they ignore these foundations. This all-time classic episode from 2024, has host Dave Asprey joined by Mark Hyman, a practicing physician and one of the most respected leaders in functional medicine. Dr. Hyman is the founder and senior advisor of The UltraWellnessCenter, the founder and former head of strategy and innovation at the Cleveland Clinic Center for Functional Medicine, and a long time advocate for treating root causes instead of managing disease. With over 30 years of clinical experience, his work focuses on restoring mitochondrial health, optimizing metabolism, reversing chronic disease, and slowing biological aging using science backed interventions. Together, Dave and Mark dismantle common myths around protein, carnivore diets, ketosis, fasting, supplements, and longevity drugs. They explain why sugar accelerates aging faster than protein, how mTOR must cycle instead of staying suppressed, and why muscle, mitochondria, and metabolic flexibility matter more than calorie restriction. The conversation also covers nootropics, sleep optimization, neuroplasticity, AI driven diagnostics, and how functional medicine reframes aging as a reversible biological process rather than an inevitable decline. You'll learn: • How insulin and nutrient sensing control aging speed • Why mitochondria sit at the center of longevity and disease • The truth about mTOR, fasting, and protein intake • How ketosis and metabolic flexibility protect long term health • Where supplements and nootropics actually fit in brain optimization • Why functional medicine outperforms symptom based care • How AI and advanced testing are reshaping modern medicine Thank you to our sponsors! - MASA Chips | Go to https://www.masachips.com/DAVEASPREY and use code DAVEASPREY for 25% off your first order. -ARMRA | Go to https://tryarmra.com/ and use the code DAVE to get 15% off your first order. -OneSkin | Try OneSkin for 15% off with code DAVE at https://www.oneskin.co/DAVE. Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade brings you the knowledge to take control of your biology, extend your longevity, and optimize every system in your body and mind. Each episode delivers cutting-edge insights in health, performance, neuroscience, supplements, nutrition, biohacking, emotional intelligence, and conscious living. New episodes are released every Tuesday, Thursday, Friday, and Sunday (BONUS). Dave asks the questions no one else will and gives you real tools to become stronger, smarter, and more resilient. Keywords: longevity biohacking, functional medicine longevity, biological age reversal, mitochondria and aging, mTOR pathway aging, insulin resistance and aging, metabolic flexibility, fasting and longevity, ketosis and metabolism, protein intake and mTOR, muscle and longevity, inflammaging, chronic inflammation aging, mitochondrial dysfunction, nutrient sensing pathways, rapamycin longevity, metformin longevity debate, carnivore diet longevity, sugar and aging, brain optimization longevity, neuroplasticity and aging, sleep optimization biohacking, supplements for longevity, anti aging metabolism, human performance optimization, Dave Asprey longevity, Mark Hyman longevity Resources: • Mark's Website: https://drhyman.com/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Upgrade Collective: https://www.ourupgradecollective.com • Upgrade Labs: https://upgradelabs.com • 40 Years of Zen: https://40yearsofzen.com Timestamps: 0:00 - Trailer 0:45 - Introduction 4:49 - Aging as a Treatable Disease 7:50 - The Hallmarks of Aging 14:23 - Nutrient Sensing and Longevity Switches 17:37 - Time Restricted Eating and Autophagy 20:44 - The Four Longevity Pathways 21:49 - Metformin Debate 25:30 - Ozempic and Weight Loss 28:42 - Rapamycin and mTOR 36:23 - Meat, Protein, and Aging 39:46 - Protein Quality and Muscle Synthesis 45:50 - Protein Timing for Muscle Building 48:08 - Metabolic Flexibility 51:32 - Inflammaging 55:26 - Zombie Cells and Senescence See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The news to know for Tuesday, December 23, 2025! We're talking about the next push to expand the immigration crackdown in the U.S. in the new year. And why dozens of American diplomats were just removed from their jobs. Also: what to expect from a new "Trump class" of Navy battleships. Plus: approval for a promising new weight-loss pill that's like Ozempic, controversy surrounding a 60 Minutes episode that hasn't aired, and new artwork from the elusive street artist Banksy—that seems a bit different from much of his other work. Those stories and even more news to know in about 10 minutes!    Join us every Mon-Fri for more daily news roundups!  See sources: https://www.theNewsWorthy.com/shownotes Become an INSIDER to get AD-FREE episodes here: https://www.theNewsWorthy.com/insider Get The NewsWorthy MERCH here: https://thenewsworthy.dashery.com/ Sponsors: You can get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/NEWSWORTHY and using code NEWSWORTHY at checkout. To advertise on our podcast, please reach out to ad-sales@libsyn.com    

Plus: The U.S. bans new China-made drones from DJI and Autel Robotics, sparking outrage among pilots. And U.S. regulators approve the first GLP-1 weight-loss pill, a tablet formulation of Novo Nordisk's Ozempic and Wegovy. Daniel Bach hosts. Sign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Lionel delivers an entertaining and informative look at a world facing "existential threats," ranging from AI and globalist agendas to the "Ozempic face" of modern culture. Whether he's dismantling the "prison industrial complex," arguing for the legalization of drugs to destroy cartel profits, or critiquing the current state of the Republican party, Lionel cuts through the "petty talk" to get to the heart of the fight for our lives. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Lisa Fischer Said, Lisa Fischer sits down with nutritionist and weight loss expert Erin Power for a candid, myth-busting conversation about women's health, appetite, and sustainable weight loss. They unpack why dieting fails women—especially in midlife—and how hunger hormones, circadian rhythms, protein intake, menopause, and metabolic health actually work together. From breaking free of "diet culture" and the demure female eating pattern to navigating GLP-1 medications, fasting, and eating to true satiety, this episode offers a refreshing, science-backed approach to food, body trust, and long-term health for women over 40.     WEBSITE: https://www.themetabolicmentorship.com/masterclass     INSTAGRAM: https://www.instagram.com/eat.simple.erin     FACEBOOK: https://www.facebook.com/eatsimple.ca     FACEBOOK GROUP: https://www.facebook.com/groups/eatsimplecommunity     EPISODE SPONSOR:  https://www.ralstonfamilyfarms.com/     EPISODE SPONSOR:  https://www.akelscarpetone.com/     LISA'S LINKS:     Lisa Fischer Said Academy:  https://lisafischersaid.com/academy/     Website:  lisafischersaid.com     For more information on group intermittent fasting  coaching with Lisa, email fasting@lisafischersaid.com     For more information on one-on-one or group health coaching with Lisa, email healthcoaching@lisafischersaid.com     Podcast produced by clantoncreative.com    

Alors que 14 % de Français souffrent d'obésité, un traitement médicamenteux, le Wegovy, est commercialisé depuis le 8 octobre 2024 en France, mais sous conditions strictes : ce médicament amaigrissant ne peut être retiré en pharmacie que sur ordonnance et sans être remboursé, et uniquement par des patients atteints d'obésité morbide et âgés de moins de 65 ans.Le Wegovy appartient à une nouvelle famille de médicaments dite des « analogues du GLP-1 », qui suscite, à l'instar de l'Ozempic, un espoir inédit chez les patients comme au sein du corps médical. Sans graves effets secondaires, les pertes de poids spectaculaires qu'ils engendrent promettent de lutter efficacement contre l'obésité mais provoquent également un certain nombre de dérives.Dans cet épisode de « L'Heure du Monde », Pascale Santi, journaliste au service Santé du Monde, détaille pourquoi ces nouveaux traitements suscitent tant d'attentes face à cette maladie, qui touche actuellement plus d'un milliard de personnes dans le monde.Un épisode de Marion Bothorel. Réalisation : Thomas Zeng. Musiques : Amandine Robillard. Présentation et suivi éditorial : Adèle Ponticelli. Rédaction en chef : Jean-Guillaume Santi.Dans cet épisode : extraits d'interviews d'Etienne, patient participant à l'essai clinique en France, du médecin Olivier Ziegler et du correspondant du Monde à Washington, Arnaud Leparmentier, d'une conférence donnée par Oprah Winfrey le 23 septembre 2023, de deux reportages consacrés à l'Ozempic diffusés sur E ! News le 4 juillet 2023 et sur USA Today le 18 octobre 2022, ainsi qu'une publicité d'Ozempic diffusée en 2023.Un épisode publié le 10 octobre 2024---Pour soutenir "L'Heure du Monde" et notre rédaction, abonnez-vous sur abopodcast.lemonde.fr Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Nokukhanya Mntambo speaks to Dr. Pfunzo Machimana, GP & Family Physician Specialist, about how appetite-suppressing drugs like Ozempic and Wegovy are reshaping weight-loss approaches in South Africa, with growing interest in their role beyond diabetes management and implications for diet and health. The Money Show is a podcast hosted by well-known journalist and radio presenter, Stephen Grootes. He explores the latest economic trends, business developments, investment opportunities, and personal finance strategies. Each episode features engaging conversations with top newsmakers, industry experts, financial advisors, entrepreneurs, and politicians, offering you thought-provoking insights to navigate the ever-changing financial landscape.    Thank you for listening to a podcast from The Money Show Listen live Primedia+ weekdays from 18:00 and 20:00 (SA Time) to The Money Show with Stephen Grootes broadcast on 702 https://buff.ly/gk3y0Kj and CapeTalk https://buff.ly/NnFM3Nk For more from the show, go to https://buff.ly/7QpH0jY or find all the catch-up podcasts here https://buff.ly/PlhvUVe Subscribe to The Money Show Daily Newsletter and the Weekly Business Wrap here https://buff.ly/v5mfetc The Money Show is brought to you by Absa     Follow us on social media   702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/CapeTalk 702 on YouTube: https://www.youtube.com/@radio702   CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/Radio702 CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Welcome to Ozempic Weightloss Unlocked, the podcast where we explore the latest news and breakthroughs surrounding one of today's most talked about medications.I'm your host, and today we're diving into what you need to know about Ozempic and its growing role in weight management and health.Let's start with the basics. Ozempic is a medication originally approved by the FDA for managing Type 2 diabetes. But here's where it gets interesting. The medication contains semaglutide, the same active ingredient found in Wegovy, which was specifically approved as an anti-obesity treatment. According to Cleveland Clinic, when Ozempic is prescribed for weight loss, it's considered off-label use, meaning doctors are prescribing it for a purpose beyond its original FDA approval.So how does it actually work? Ozempic belongs to a class of medications called GLP-1 receptor agonists. These drugs mimic a hormone your digestive tract naturally produces. When you take Ozempic, your body produces more of this hormone, which decreases your appetite and makes you feel fuller. But it does more than just suppress hunger. Cleveland Clinic explains that semaglutide changes how your body responds to food and weight loss by affecting the signaling between your gut and brain. This is significant because it treats obesity as a metabolic disease, not simply a behavioral problem.The weight loss results speak for themselves. In a landmark study cited by Cleveland Clinic, people using semaglutide combined with lifestyle changes lost about fifteen percent of their body weight in sixty-eight weeks, averaging thirty-four pounds. Those who didn't take the medication lost only about six pounds on average.But listeners, there's an important reality to understand. These medications aren't quick fixes. According to Cleveland Clinic, people often regain weight once they stop taking the medication. A follow-up study mentioned by Sword Health found that people who stopped semaglutide regained about two-thirds of the weight they lost within a year.Here's another critical point. Research shows that up to thirty-nine percent of weight lost on these medications can come from lean muscle, not just fat. This matters because muscle supports your metabolism. When you lose muscle, your body burns fewer calories, which can lead to weight loss plateaus. The solution isn't eating less. According to Sword Health, the most effective approach is preserving and rebuilding muscle through strength-focused movement.It's also important to know that Ozempic isn't suitable for everyone. Cleveland Clinic warns against obtaining these medications through unverified sources or compounded versions. The safety and effectiveness of compounded versions haven't been formally tested and may act differently in your body than FDA-approved versions.Cost remains a significant barrier. Cleveland Clinic notes that these medications can be expensive due to limited insurance coverage, which is why some listeners might be tempted to seek cheaper alternatives online. But that's where caution is essential.Looking ahead, research is exploring additional benefits beyond weight loss. These medications are now being studied for potential effects on aging and other health conditions.The bottom line for our listeners is this: Ozempic can be a powerful tool for managing obesity when combined with lifestyle changes and professional medical supervision. But it requires a long-term commitment and shouldn't be viewed as a quick solution.Thank you for tuning in to Ozempic Weightloss Unlocked. Please subscribe for more episodes exploring the latest developments in weight management medicine and health innovation.This has been a Quiet Please production, for more check out quiet please dot ai. Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

Chappelle's Netflix special angers both sides, Eli Zaret joins us as the Detroit Lions season ends, Jeffrey Epstein files released, Bowen Yang exits SNL, NASCAR's Greg Biffle plane crash, D4vd's burn cage, and more entitled Nick Reiner information. Eli Zaret joins the show to recap the Detroit Lions season-killing loss to the Pittsburgh Steelers, DK Metcalf vs the fans, the Chicago Bears incredible win over the Green Bay Packers, go over the CFB playoff games over the weekend, Michigan's search for their next head coach, Arizona State QB Sam Leavitt NIL offers, the Jake Paul/Anthony Joshua spectacle, Amon-Ra St. Brown's boogers, Puka Nacua's racist mistake, Jared Goff's Christmas presents, a bet on a Shohei Ohtani ball, the Detroit Pistons hot run and more. A brand new David Chappelle special dropped out of nowhere on Netflix. Dave made a lot of money in Saudi Arabia. Bowen Yang leaves Saturday Night Live midseason. His final sketch to send him off was pretty weak. Noah Weiland really misses his dog. “Do your thing, internet”. Bill Clinton is the big loser in the release of the latest Jeffrey Epstein files. They come heavily redacted and posted pictures disappeared a day later. The Brown University shooter was found dead of a self-inflicted gunshot wound. NASCAR's Greg Biffle and family dead in plane crash. Zion Williamson allegedly slid into Sydney Sweeney's DM's. Jerry Garcia was no fan of Jim Morrison or The Doors. Steven Tyler and his 38-year-old girlfriend break up. More and more info-dumps are dropping regarding Nick Reiner. He's using schizophrenia as an excuse. Conan O'Brien could have saved Rob and Michele Reiner. Luigi Mangione is having some good luck in court lately. We watch as a drunk couple make absolute fools of themselves. Katie Price is looking awfully fake and too thin these days. Christina Aguilera looks pretty damn good after Ozempic. D4vd had a ‘burn cage' and it doesn't look suspicious at all. The Oscars are moving to YouTube. TV is a dying medium. Jimmy Kimmel had a tough year and cried about it. Harvard wants to know who filmed and released a clip of Larry Summers. Merch is still available. Click here to see what we have to offer for a limited time. If you'd like to help support the show… consider subscribing to our YouTube Channel, Facebook, Instagram and Twitter (Drew Lane, Marc Fellhauer, Trudi Daniels, Jim Bentley and BranDon).

Episode 116: Today I'm sitting down with the founders of MARA Labs, Dr. John Gildea and David Roberts, for a real conversation about inflammation, detox pathways, and metabolic health. They dive into the benefits of sulforaphane (and why it's one of the most researched compounds for cellular health), how berberine actually works in the body, and how their supplement, GLPERFECT compares to Ozempic. We also talk about the rise of Ozempic and GLP-1 medications. They tell us the benefits, the risks, and what most people are missing when they jump straight to medication without understanding their inflammation, blood sugar, or lifestyle first.If you've ever wondered what moves the needle for longevity, detox pathways, metabolic support, or gut health, this episode breaks it down in a way that finally makes sense.Whether you're supplement-curious or navigating the Ozempic conversation yourself, this is a must-listen for anyone who wants real, sustainable health, not shortcuts.Hi Gracie!! Sorry for all the texts- just letting you know the Jones Road copy is in! Also, when you're taping that spot could you tape the below CTA for the Mara Labs episode? They wanted to specify the end date :) :For the next week, Wellness Her Way loyal listeners can get an exclusive 28% off all Mara Labs products when you go to www.mara-labs.com/GRACIE and use code GRACIE at checkout. After December 29th, the code will return to the standard 15% off.Connect with Mara Labs: HERESupplements mentioned: BROCELITE, BERBELITE, & GLPERFECT CONNECT WITH ME:Cookin Up Wellness Ebook: HERE Nite Nectar Restock: HERE Instagram: @Gracie_NortonWellness Her Way Instagram: HEREProduced by Dear MediaSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

100 episodes?! Cue the confetti, friends!

In this episode, Dr. Vaughn Lawrence exposes the hidden dangers of acetaminophen (Tylenol), NyQuil, and other common painkillers, including liver damage, glutathione depletion, and mitochondrial stress. He shares effective natural pain relief alternatives like turmeric-based formulas, ginger, CBD, and kratom, and explains how to choose clean supplements and protein powders that are free from heavy metals. To find out how we can help you on your health journey, book a free 15-minute Discovery Call with one of our New Client Coordinators! Click the link: https://www.spiritofhealthkc.com/discoverycall For more health tips and information visit: https://www.spiritofhealthkc.com/To buy natural health supplements visit: http://store.spiritofhealthkc.com Facebook: https://www.facebook.com/SpiritofHealth/ Instagram: https://www.instagram.com/spiritofhealthkc/ Pinterest: https://www.pinterest.com/spiritofhealthkc/YouTube: https://www.youtube.com/channel/UCwRcNSxR3kMYi9wP8OmxlQQ Spotify: https://open.spotify.com/show/7yfBBUjWKk3yJ3auK71O7H?si=295c77ed21f14568&nd=1&dlsi=af01c00121ed4aed

GLP-1 medications like semaglutide and Ozempic are already being used by gym members, and most gym owners have no plan for it.In this episode of the Sweat Success Podcast, we break down how GLP-1 weight-loss drugs, hormone replacement therapy (HRT), and telehealth are changing the fitness industry, and what gym owners, CrossFit affiliates, and personal trainers need to understand right now.This conversation covers:What GLP-1 drugs and semaglutide actually do in the bodyWhy gym members are already using weight-loss medicationThe biggest risks of ignoring GLP-1s inside gymsHow inflammation, hormones, and food noise impact fitness resultsThe difference between unsafe shortcuts and guided medical wellnessHow gyms can talk about GLP-1s ethically without prescribing or crossing linesWhy GLP-1s can increase gym attendance, intensity, and retentionIf you're a gym owner, personal trainer, or fitness business operator, this episode will help you understand the reality of GLP-1 medications in fitness before misinformation or fear costs you trust and members._______________________________________________________________________________________________Dave Appel is a gym owner and medical wellness operator working at the intersection of fitness, hormones, and telehealth. Follow him for real-world insights on GLP-1s, HRT, recovery, and the future of fitness and healthcare.https://www.solacrossfit.com/   / dappelfit19  _______________________________________________________________________________________________Subscribe to the Sweat Success Podcast!! 

Share your guest suggestions hereMail - connect@beerbiceps.comLink - https://forms.gle/aoMHY9EE3Cg3Tqdx9Check out BeerBiceps SkillHouse's YouTube 1O1 Course - https://youtube.beerbicepsskillhouse.in/youtube-101BeerBiceps SkillHouse को Social Media पर Follow करे :-YouTube : https://www.youtube.com/channel/UC2-Y36TqZ5MH6N1cWpmsBRQ Instagram : https://www.instagram.com/beerbiceps_skillhouseWebsite : https://beerbicepsskillhouse.inFor any other queries EMAIL: support@beerbicepsskillhouse.comIn case of any payment-related issues, kindly write to support@tagmango.comLevel Supermind - Mind Performance App को Download करिए यहाँ से

It has been a busy year! The Epstein files were released, Prince Andrew is no longer a prince, The Lionesses won the Euros and Ozempic has taken hold of Hollywood. And they are just a few non-Donald Trump related headlines.Giles Whittell is joined by The Observer's Jeevan Vasagar, Poppy Bullard and Jessy Parker Humphreys, as they battle it out and pitch the top stories of the year. **We want to hear what you think! Email us at: newsmeeting@observer.co.uk Follow us on Social Media: @ObserverUK on X @theobserveruk on Instagram and TikTok@theobserveruk.bsky.social‬ on bluesky Host: Giles Whittell Producer: Casey Magloire & Amalie SortlandExecutive Producer: Rebecca Moore To find out more about The Observer:Subscribe to TheObserver+ on Apple Podcasts for early access and ad-free contentHead to our website observer.co.uk Download the Observer app – for a listening experience curated by our journalists Hosted on Acast. See acast.com/privacy for more information.

EDVIN TÖRNBLOM gästar podden och tycker till om Måndagsvibe's olika uttalanden. Är det så fel att åka till Dubai, ta Ozempic, eller prata öppet om skönhetsoperationer? Men framförallt – fördomar finns ch hur många nollor finns det på Edvins bankkonto? Följ oss på instagram och Tiktok @mandagsvibe, gå med i facebookgruppen "Måndagsvibbare" och skicka frågor, dilemman, am I the asshole och fuckboy or not till mandagsvibepodd@gmail.com. Hadeee!

GLP-1 weight loss drugs like Ozempic and Wegovy are being called a miracle for obesity—but what's really happening inside the body?In this episode of The Whole Body Detox Show, host David DeHaas of Living Waters Wellness Center sits down with renowned nutrition expert Jonny Bowden, PhD, known as The Nutrition Myth Buster, to unpack the science, the benefits, and the hidden risks behind GLP-1 medications.Together, they break down what GLP-1 (glucagon-like peptide-1) really is, why these drugs shut down cravings so effectively, and how they've become so powerful that they've altered the economy of Denmark. More importantly, they reveal the physiological consequences most people aren't warned about—especially the reality that up to 40% of the weight lost on GLP-1 drugs may be muscle, not fat.This conversation explores how GLP-1 drugs impact insulin resistance, metabolism, liver health, nutrient depletion, brain fog, and long-term weight regain, and why losing weight without healing the gut, detoxifying the body, and restoring metabolic balance can leave people weaker, inflamed, and frustrated—even at a lower number on the scale.You'll also hear why hunger suppression creates a “low-calorie trap,” how protein and essential nutrients become critical, and what must be done to protect muscle, energy, and long-term health for those currently using—or considering—GLP-1 medications.This episode does not demonize GLP-1 drugs, but it does expose the Trojan horse effects behind rapid weight loss and explains why real food, gut health, toxin removal, stress management, and whole-body healing are essential for sustainable results.and watch The Four Natural Laws of Healing, or explore the 10-Day Healing Retreat at Living Waters Wellness Center.To learn more about Jonny Bowden, PhD, his research, books, and clinical insights, visit his official website:https://www.jonnybowden.com/If you or someone you love is considering—or already using—GLP-1 weight loss drugs, this episode is essential listening.Learn more about natural, sustainable healing and long-term metabolic restoration by visitingSupport the show Ready for your healing journey?Visit our website: www.LivingWatersCleanse.com Or give us a call at: (208) 378-9911Stem Cell Activation Patches:www.StemCellPatch.netGet your Supplements and Natural Body Products Here:www.livingwaterscleanse.com/supplementsQI-Shield EMF Devices:Protect your whole home or office with a touric shield from EMF's. 1. QI Shield Covers 16'x16' 2. QI Home Covers 50' x 50' 3. QI Max Covers 250'x250'Click on link and enter Livingwaters in discount code section during checkout Magnesium Soaks:Follow us on our socials: Living Waters Wellness CenterBitChute: www.bitchute.com/livingwaterswellnessRumble: www.rumble.com/l...

In this week's episode, I take a look back at my writing goals for 2025, and see how many of them I met. I also take a loog ahead at my writing goals for 2026. This coupon code will get you 25% off the ebooks in my Anthologies series at my Payhip store: STORIES2025 The coupon code is valid through December 29, 2025. So if you need a new ebook this winter, we've got you covered! 00:00:00 Introduction and Writing Updates Hello, everyone. Welcome to Episode 282 of The Pulp Writer Show. My name is Jonathan Moeller. Today is December 19th, 2025 and today I'm taking a look back at my writing goals from the start of 2025 and seeing how many of them I reached. We'll also take a look ahead at my writing goals for 2026. Before we get to that, we will have Coupon of the Week and a progress update on my current writing projects. This week's coupon code will get you 25% off the ebooks in my anthology series at my Payhip store. And that is STORIES2025. And as always, I will put the coupon code and a link to the store in the show notes. This coupon code is valid through December 29th, 2025, so if you need new ebook to read as you travel for this upcoming Christmas week, we have got you covered. A reminder that the anthology series is collections of my short stories, which I tend to release every year. And in fact, next month, if all goes well, we'll have 2025: The Complete Short Stories. Now for an update on my current writing projects. Wizard-Assassin, the fifth book in the Rivah Half-Elven series is now done. By the time this episode goes live, you should be able to get it off Amazon and Kindle Unlimited since it is my series that is in Kindle Unlimited. So I hope if you are looking for something to read, you will give that a shot. Now that Wizard-Assassin is done, my main project is going to be Blade of Storms, which will be the third book in my Blades of Ruin epic fantasy series. And I believe I'm 12,000 words into that. I'm hoping to have that out in January, but depending on how January goes, it might slip to February, but January would be ideal. And after that, my next main project will be Cloak of Summoning, the 14th book in the Cloak Mage series. And I literally just started it this morning before I went to the gym, which puts me at 250 words into it, so there's definitely a ways to go in that. In audiobook news, we are still waiting on Cloak of Embers (as excellently narrated by Hollis McCarthy) to get through processing at the various platforms, which always, as you imagine, tend to slow down this time of year. And Brad Wills has just started working on recording for Blade of Shadows. So hopefully we should have Cloak of Embers available for you at all platforms before too much longer. And Blade of Shadows will probably be our first audiobook for 2026. So that is where I'm at with my current writing, publishing, and audiobook projects. 00:02:28 Main Topic: 2025's Writing Goals and My Writing Goals for 2026 And speaking of 2026, in this week's episode, we're going to take a look back at my writing goals for 2025, see how many of them I met, and then look ahead for my writing goals to 2026, which is in fact just around the corner. So first off, a big thank you to everyone who read one of my books over the year of 2025. 2025 for me was an interesting year, both in a personal and a professional way, and sometimes in both the good and bad senses of the word interesting. Sales were down from 2024, but given all the economic turbulence of the year, I am grateful they were only down a relatively small amount compared to 2024. Facebook ads went from my main advertising platform at the start of 2025 to near uselessness by the end of the year due to all the AI nonsense Meta has injected into them. Spotify converted Findaway Voices to Inaudio and made a total mess of it this summer, which after that got settled is why I now upload my audiobooks directly to Google Play and Kobo rather than through Findaway Voices. It seems like a lot of companies are pursuing AI in the desperate hope that it will somehow magically become profitable even as the expense of running AI services devours them from the inside out and renders them incompetent at their primary missions. I was so annoyed at all the half-baked AI stuff Microsoft shoved into Windows 11, I did all my writing on a Mac Mini this year and have been pretty happy with it as a writing platform. Apple, of course, has AI stuff as well, but what Apple has that Microsoft doesn't is a switch that flips it all off at the system level and doesn't do any "install later" passive aggressive crap that Microsoft does. On the plus side, my Super Summer Of Finishing Things let me finish The Shield War, Stealth & Spells Online, and Ghost Armor one after another. Five unfinished series at once was too many. Three has been more manageable. And after five years, I finally got my weight down to what it was before COVID in 2025. Watching some relatives go on Ozempic and the side effects they experienced was very inspirational in the sense of wanting to avoid that experience myself. I thought I would take a lot of exercise and vegetables to do lose weight. It turns out instead it takes a whole freaking lot of exercise and a truly staggering quantity of vegetables. I tell myself the carrot sticks are really just like potato chips when I eat them, and I can almost convince myself of it. They're crunchy, right? Just like potato chips. I told myself that often enough that I very, nearly almost believe it. So let's start with a look back at my writing goals for 2025 and see how many of them I reached. #1: Write as many new words as possible, hopefully hitting one million new words of fiction in 2025. And I'm pleased to report that I hit this one. 2025 was the second year in a row where I reached a million words of new fiction and will come in at 1.12 million words with Wizard-Assassin. It did get a bit tight, but I passed the million word mark with Blade of Shadows in November, so is a nice milestone to reach. Two years of a million words in a row! #2: Finish The Shield War. I did that one! Shield of Power, the final book in The Shield War series, came out in July. It's even available in audiobook (as excellently narrated by Brad Wills). #3: Finish Ghost Armor. I did this one as well. Ghost in the Siege, the final book in the Ghost Armor series, came out in August. It's also available in audiobook (as excellently narrated by Hollis McCarthy). #4: Continue Cloak Mage. There was a year gap after Cloak of Illusion, but I'm pleased to report I finally got back to Cloak Mage with Cloak of Worlds in October. As I mentioned earlier, in 2024, I had five unfinished series, which is way too many. So my goal was to finish some and then limit myself to only three unfinished series at any one time. By the end of summer 2025, I successfully achieved that. So going forward (barring any illness or Unexpected Events), there shouldn't be another year-long gap between Cloak Mage books. In fact, I'm hoping to write the outline for Cloak of Summoning this weekend, if all goes well. And in fact, I started this morning. #5: Continue Half-Elven Thief. It went down to the wire with only 12 days left in the month, but I was able to publish Wizard-Assassin and meet my goal. Like with Cloak Mage, there's a yearlong gap between the books, but that should be much shorter going forward. I'm hoping to start work on Rivah #6 in March or February, if all goes well. #6: Conclude Stealth & Spells Online. I did this as well. I'm not going to lie, it really was quite challenging. I originally thought of Stealth & Spells Online as a seven or eight book series, but it sold weakly enough that I didn't want to put six books' worth of effort into it. So I thought about it and figured out how to wrap up the story in one volume, and I wrote most of it at 500 words a day from like October 2024 to July 2025, squeezing it between other things as time allowed. Then in July, I was far enough along from all that cumulative work that I finished it in like one quick burst. I think I had only like one full-time day working on it. So I'm very glad that people liked the ending for the trilogy and thought that it worked. I'm hoping to release a single volume edition of the audiobook sometime in 2026, if all goes well. Fun fact: the book was 116,000 words long, and since I published 1.12 million new words in 2025, it was in fact Stealth & Spells Online: Final Quest that got me over the million word mark. #7: New epic fantasy series in the Andomhaim/Frostborn world. I did that as well with Blade of Flames and Blade of Shadows. As I mentioned before, I'm about 12,000 words in Blade of Storms, and hopefully that will be the first book I publish in 2026, ideally in January, but it might slip to February. #8: New audiobooks as time, budget, and narrator availability allow. This worked out as well. Like I said, in 2024, I've brought as many of my old series into audio as I'm going to, so instead we're going to focus on recording the books in the new series. We have books from The Shield War and Blades of Ruin narrated by Brad Wills, new books from Ghost Armor and Cloak Mage [narrated] by Hollis McCarthy, and a new Half-Elven Thief audiobook [narrated by] Leanne Woodward. So I am pleased to say that I met all my 2025 writing goals. Now with that in mind, let's take a look at what I would like to do in 2026. I'm not planning on starting anything new in 2026, but I don't think I'll reach the end of any ongoing series in that year. So basically 2026 will be The Year of Continuing. #1: Publish a million words of new fiction. I'm going to try and hit a million words again, but there's a chance ... I'm going to say right up front, there's a chance it might not work out in 2026. I'm going to have to spend at least a couple of weeks on travel, and I know for sure there are a couple of mandatory Real Life Activities that will take up an unknown amount of time. The older I get, the more I can emphasize with former UK Prime Minister, Harold McMillan when he said his biggest problems were "events, dear boy, events." But assuming we can avoid too many "events," I will aim to publish a million new words of fiction in 2026. #2: Continue Blades of Ruin. I also want to continue with Blades of Ruin, which will be my main series for a while. I'm planning for 12 books in this series, so we should hopefully make some good progress with it in 2026. #3: Continue Cloak Mage. I would also like to continue Cloak Mage in 2026. Cloak of Worlds was number 13 in the series and I'm planning for 18. Since I'm only working on three series at a time now, like I said before, we shouldn't have those yearlong gaps between books like I've had in the past for Cloak Mage. #4: Continue Half-Elven Thief. I'm also continuing Half Elven Thief in 2026. I had planned for six books originally, but there was just too much story to fit into six, so we're going to end up with nine. So I'm planning to continue that in 2026 as well. There was a year's gap between Orc-Hoard and Wizard-Assassin like there was with Cloak Mage but hopefully won't have as big a gap for Half-Elven Thief now that I'm only writing three series at the same time. #5: New audiobooks as time, budget, and narrator availability allow. I did this in 2025 and it worked pretty well. I don't want to bring any more of my old backlist books into audio, but instead I'll focus on Blades of Ruin, Cloak Mage, and Half-Elven Thief as time, budget, and narrator availability permit. #6: Other opportunities as available. I think it is fair to say we live in turbulent times, which is often unsettling. The flip side is that sometimes this can bring unexpected opportunities your way, so it's wise to remain alert and flexible. So we will see what 2026 brings. So those are my six writing goals for 2026. Once again, thanks for reading and listening. I hope I have new books for you to read in 2026. And as ever, when I make plans for the new year, it seems like a good idea to reflect on this quote from the book of James: "Go to now, ye that say, Today or tomorrow we will go into such a city, and continue there a year, and buy and sell, and get gain: Whereas ye know not what shall be on the morrow. For what is your life? It is even a vapour, that appeareth for a little time, and then vanisheth away. For that ye ought to say, If the Lord will, we shall live, and do this, or that." So that is it for this week. Thank you for listening to The Pulp Writer Show. I hope you found the show useful. A reminder that you can listen to all the back episodes on https://thepulpwritershow.com. If you enjoyed the podcast, please leave your review on your podcasting platform of choice. Stay safe and stay healthy and see you all next week.  

GLP-1 drugs have become one of the most important developments in the pharmaceutical industry. With products like Ozempic, Wegovy, and Mounjaro in high demand, competition between drug makers is growing quickly. In this episode of Down to Business English, Skip Montreux and Dez Morgan get Down to Business with GLP-1 inhibitors — the drugs behind today's weight-loss boom. They explain who the main players are, including Novo Nordisk and Eli Lilly, and compare their leading products. Their discussion also looks at a major recent development: Pfizer's acquisition of biopharma startup Metsera, and why this deal could significantly change the market. Skip and Dez's conversation gives listeners a clear and practical introduction to competition and strategy in the pharmaceutical industry — while helping you improve your Business English. In this episode, you will learn: What GLP-1 drugs are and what they are used for. The main differences between Ozempic, Wegovy, Mounjaro, and Zepbound. Why Eli Lilly is gaining market share, especially in North America. How Pfizer's acquisition could affect future weight-loss treatments. Do you like what you hear? Become a D2B Member today for to access to our -- NEW!!!-- interactive audio scripts, PDF Audio Script Library, Bonus Vocabulary episodes, and D2B Member-only episodes. Visit d2benglish.com/membership for more information. Follow Down to Business English on Apple podcasts, rate the show, and leave a comment. Contact Skip, Dez, and Samantha at downtobusinessenglish@gmail.com Follow Skip & Dez Skip Montreux on Linkedin Skip Montreux on Instagram Skip Montreux on Twitter Skip Montreux on Facebook Dez Morgan on Twitter RSS Feed

"Send me a text"Welcome to part two where we unpack the final six trends that will separate winning supplement brands from dying ones in 2026.In this episode, we dive into the innovation happening in formats and packaging (hint: gummies are declining at 8% while powders grow), the explosion of GLP-1 natural alternatives riding the Ozempic wave, functional mushrooms hitting mainstream with lion's mane getting 87 million TikTok views, personalized supplements becoming accessible through DNA and AI, beauty-from-within supplements booming as skincare goes internal, and why immune health isn't declining post-pandemic it's accelerating to $27.6 billion.You'll discover why generic is dead and specificity is king, how to prove your products actually work in a skeptical market, why format matters as much as formulation, and the fundamental consumer behavior shifts connecting all twelve trends.Plus, the hard truth about market growth: specialty supplements are growing at 6.3% while basic vitamins barely hit 2.7%. If you're making generic multivitamins with no differentiation, you're in a category growing slower than inflation.The supplement market is hitting $327 billion by 2030, but not every brand will capture their share. This episode shows you exactly how to position your brand for the massive opportunities ahead while your competitors keep playing the old game.The revolution isn't coming, it's already here. Are you ready?If you're interested in working with me and my team to improve your supplement business. You can learn more at my website https://creativethirst.com Click here to grab your copy of the Health Supplement Ad Swipe Guide. Discover what really works in funnel marketing Need help increasing sales on your own? Click here Stuck at $1 - $5M in revenue? Click Here Case Study on how Creative Thirst added over $200,000 for one supplement brand

Broadcast from KSQD, Santa Cruz on 12-18-2025: Dr. Dawn opens by examining how market competition is actually working in the weight loss drug sector. Novo Nordisk's Ozempic and Wegovy compete against Eli Lilly's Monjaro and ZepBound, with prices dropping nearly 50% as companies launch direct-to-consumer websites. The main barriers remain needles and refrigeration, driving development of oral versions. Novo's Wegovy pill awaits FDA approval for early 2026 launch at $150 monthly. Next-generation drugs show remarkable results: Eli's retatrutide causes 24% weight loss in 48 weeks, while Novo's Cagrisema combines semaglutide with amylin to reduce muscle loss. Pfizer paid $10 billion for Metsera's once-monthly drug despite significant side effects. A quick fiber tip suggests adding plain psyllium to morning coffee for cardiovascular and microbiome benefits. Start with half a teaspoon and work up to two teaspoons (10 grams) over several weeks to avoid gas. The prebiotic fiber improves glucose tolerance and may reduce cancer risk. UC San Diego scientists discovered why cancers mutate so rapidly despite being eukaryotic cells with protected chromosomes. The answer is chromothripsis, a catastrophic event where the enzyme N4BP2 literally explodes chromosomes into fragments. These reassemble incorrectly, generating dozens to hundreds of mutations simultaneously and creating circular DNA fragments carrying cancer-promoting genes. One in four cancers show evidence of this mechanism, with all osteosarcomas and many brain cancers displaying it. This explains why the most aggressive cancers resist treatment. Research from 2013 shows any glucocorticoid use significantly increases venous thromboembolism risk, with threefold increases during the first month of use. The risk applies to new and recurrent clots, affecting both oral and inhaled steroids, though IV poses highest risk and topical the lowest. Joint injections fall somewhere between inhaled and oral. Anyone with prior blood clots should avoid steroids except for life-threatening situations like severe asthma attacks requiring ventilation. A meta-analysis of 20 randomized controlled trials shows creatine supplementation helps older adults (48-84) maintain muscle mass when combined with weight training two to three times weekly. The supplement provides no benefit without exercise. Recommended dosing starts at 2 grams and works up to 5 grams daily. Vegans benefit most since they consume little meat or fish. Important caveat: creatine throws off standard kidney function tests (creatinine), so users should request cystatin C testing instead for accurate renal health assessment. A new JAMA study suggesting risk-based mammogram screening is fatally flawed. First, researchers offered chemopreventative drugs like tamoxifen only to the high-risk group, contaminating the study design. Second, the demographics skewed heavily toward white college-educated women, missing the reality that Black women face twice the risk of aggressive breast cancer with 40% higher mortality. Third, wild-type humans failed to follow instructions—low-risk women continued getting annual mammograms anyway while high-risk women skipped recommended extra screenings. The conclusion of "non-inferior" outcomes is meaningless given poor adherence. Stick with annual mammograms, and consider alternating with MRIs for high-risk women. The EAT-Lancet report condemns red meat based purely on observational data showing correlations with heart disease, cancer, and mortality. But people who eat lots of red meat differ dramatically from low consumers: they weigh more, smoke more, exercise less, and eat less fiber. Studies can't control for sleep quality, depression, or screen time. Notably, heavy meat eaters also die more in accidents, suggesting a risk-taking lifestyle phenotype. The inflammatory marker TMAO is higher in meat eaters, but starch is also pro-inflammatory. Eating red meat instead of instant ramen might improve health. A balanced diet with limited amounts beats epidemiology-based blanket statements. Dr. Dawn grades Dr. Oz's performance as CMS administrator. Starting at minus one for zero relevant experience, he earns plus two for promoting diet, exercise, and gut health on his show. He studied intensively after nomination, calling all four previous CMS directors repeatedly and surrounding himself with experienced staff (plus one). He finalized Medicare rules favoring prevention over surgery and earned bipartisan praise as "a real scientist, not radical" (plus one). He divested healthcare holdings but kept some blind trust interests (minus 0.5). He's developing a CMS app and partnering with Google on a digital health ecosystem (plus one), but supports ending ACA subsidies that will raise premiums for millions (minus one). He correctly promoted COVID vaccines and contradicted Trump's Tylenol-autism claims (plus one). Final score: 3.5 out of 5 possible points, the only positive score for any Trump health administrator.

On this episode we talk about a neighbors mysterious death and the ozempic hype in Hollywood.

Hour 1 of Rush to Reason ignites with John Rush joined by physician Dr. Kelly Victory and healthcare industry expert Steve House for a bold, no-holds-barred deep dive into America's health crisis. What's really driving soaring healthcare costs — accidents, or lifestyle diseases like obesity, diabetes, and hypertension? Why do “quick-fix” drugs promise miracles while risking serious side effects? Dr. Kelly and Steve challenge listeners to rethink weight loss, chronic disease, and personal responsibility, exposing how incentives in medicine and the pharmaceutical industry may be steering care in the wrong direction. They tackle blood work, drug pricing, middlemen, and the ethics of modern treatment — asking whether the system rewards sickness more than health. Is Obamacare beyond repair? Are rural hospitals on the brink? And could medical freedom begin with simple daily choices instead of another pill or injection? This hour pulls no punches, blending hard truths with practical insight as Dr. Kelly Victory and Steve House urge listeners to reclaim control of their health in 2026. Are you ready to hear what the healthcare system won't tell you? No Middleman: https://www.youtube.com/watch?v=aQhsPLcFwN8&t=70s HR2 Hour 2 of Rush to Reason opens with John Rush joined by Norton Rainey, CEO of ACE Scholarships (https://www.acescholarships.org/), for a powerful conversation on school choice and education reform. Could a new federal tax credit change everything for Colorado families? Why is Governor Jared Polis breaking ranks with his party to support competition in education — and what could that mean for public, charter, and private schools? Rainey lays out how parental choice could reshape classrooms and create a better future for kids. Then the hour shifts gears as John tackles real-world preparedness, sharing his own experience living through a prolonged power outage. Are utility shutdowns about safety — or driven by lawsuits and liability? What happens when the grid goes dark, and are you ready to handle 72 hours without power? From generators and food storage to EVs as backup power sources, John and callers dig into resilience, self-reliance, and the choices families must make in uncertain times. Education, energy, preparedness, and freedom — can one hour spark a wake-up call you didn't expect? HR3 Hour 3 of Rush to Reason delivers a powerful mix of hard truth and heartfelt inspiration as John Rush is joined by Jerzee Joe and special guest Jerry Schimel of Best Day Ministries. The hour opens with Joe dissecting a tragic plane crash and the split-second decisions that can mean life or death. From there, the conversation tackles big ideas — dependence on the state, “chemtrail” legislation, retail theft mandates, and whether electric buses make sense in cold climates. Are ideology and virtue signaling replacing common sense? Health and culture collide as Joe raises the impact of sleep on longevity, while John weighs in on President Trump's latest speech and the role of the Fed — and calls out clickbait influencers driving outrage for profit. Then the tone shifts as Jerry Schimel shares his journey into Best Day Ministries (https://bestdayministries.org/), a nonprofit that gives adults with disabilities meaningful work, dignity, and community. What happens when inclusion replaces isolation? Can purpose change lives? From aviation to politics to compassion, this hour challenges how we think — and how we live.

Shigg and Missy are continuing the conversations that are happening out there. Is there actually Ozempic for pets; all the celebrities in commercials; garlic mouthwash; 50 cent doc on Diddy; Eddie murphy being Eddie and more. Thanks for coming back and listening to us, we hope you enjoy the conversation. You rock with us, we'll rock with you. Peace.

You may have heard of Ozempic, and other GLP-1 drugs. They're everywhere. And they typically involve weekly injections — which can have a sticker price of over a thousand dollars a month. And insurance coverage has been tricky to navigate for a lot of people. That's why there's a lot of excitement around a new pill form of the drug. NPR Pharmaceuticals Correspondent Sydney Lupkin chats about these experimental pills with host Emily Kwong. Check out more of NPR's coverage about GLP-1s.Interested in more health stories? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

In this special bonus episode closing out Season 11 of The Remarkable Retail Podcast and the year 2025, hosts Steve Dennis & Michael LeBlanc complete the second half of their annual predictions review—one of the most popular and anticipated episodes of the year. The episode opens with brief but timely discussion on two high-profile retail-adjacent experiences. First us Dennis shares insights from Amazon's first-ever grocery analyst day in Seattle, offering a clearer picture of the company's “one grocery” vision and it's already substantial online presence, now being accelerated as they invest in same day deliver of perishable items.The conversation then turns to Netflix House, following Dennis's visit to the newly opened Dallas location, the second of three that are planned. Positioned in a former department store anchor, Netflix House blends immersive experiences, branded merchandise, gaming, and a restaurant. While customer traffic was encouraging, Dennis offered a frank critique of execution, citing confusing layouts, weak wayfinding, and inconsistent merchandising. The takeaway is cautiously optimistic: the concept has potential, but it is not yet operating at the level that would warrant significant expansion.The core of the episode is Part 2 of Dennis' annual predictions reckoning. Dennis revisits his forecast that department stores would continue “running to stand still,” awarding himself an A-minus as most banners remain stuck in negative or flat comps with limited progress on profitability. His prediction of significant change at Target earns a B-plus, correctly anticipating leadership transitions and the end of the Ulta partnership, though anticipated store closures did not materialize.Dennis also scores highly on his prediction that store closures would once again exceed store openings in the U.S., driven by bankruptcies and retrenchment across drugstores, mid-market apparel, and specialty retail. Predictions around Amazon's physical grocery strategy are largely validated, while expectations for a surge in retail dealmaking and IPO activity fall short, earning a candid C-minus.The episode closes with a nuanced reassessment of the so-called “Ozempic recession.” While the term itself overstated the impact, Dennis and LeBlanc agree that GLP-1 drugs are reshaping consumption patterns—particularly in food, alcohol, and apparel—with long-term implications retailers can no longer ignore.  SPECIAL OFFER for our listeners! SAVE 20% on registration for the all new Shoptalk Luxe event in Abu Dhabi January 27-29.For more info go to https://luxe.shoptalk.com/page/get-ticket and then register using our special code : RRLUXE20 About UsSteve Dennis is a strategic advisor and keynote speaker focused on growth and innovation, who has also been named one of the world's top retail influencers. He is the bestselling authro of two books: Leaders Leap: Transforming Your Company at the Speed of Disruption and Remarkable Retail: How To Win & Keep Customers in the Age of Disruption. Steve regularly shares his insights in his role as a Forbes senior retail contributor and on social media.Michael LeBlanc is the president and founder of M.E. LeBlanc & Company Inc, a senior retail advisor, keynote speaker and now, media entrepreneur. He has been on the front lines of retail industry change for his entire career. Michael has delivered keynotes, hosted fire-side discussions and participated worldwide in thought leadership panels, most recently on the main stage in Toronto at Retail Council of Canada's Retail Marketing conference with leaders from Walmart & Google. He brings 25+ years of brand/retail/marketing & eCommerce leadership experience with Levi's, Black & Decker, Hudson's Bay, CanWest Media, Pandora Jewellery, The Shopping Channel and Retail Council of Canada to his advisory, speaking and media practice.Michael produces and hosts a network of leading retail trade podcasts, including the award-winning No.1 independent retail industry podcast in America, Remarkable Retail with his partner, Dallas-based best-selling author Steve Dennis; Canada's top retail industry podcast The Voice of Retail and Canada's top food industry and one of the top Canadian-produced management independent podcasts in the country, The Food Professor with Dr. Sylvain Charlebois from Dalhousie University in Halifax.Rethink Retail has recognized Michael as one of the top global retail experts for the fourth year in a row, Thinkers 360 has named him on of the Top 50 global thought leaders in retail, RTIH has named him a top 100 global though leader in retail technology and Coresight Research has named Michael a Retail AI Influencer. If you are a BBQ fan, you can tune into Michael's cooking show, Last Request BBQ, on YouTube, Instagram, X and yes, TikTok.Michael is available for keynote presentations helping retailers, brands and retail industry insiders explaining the current state and future of the retail industry in North America and around the world.

0:00 Introduction: 11 reasons to stop weighing yourself1:07 Why you shouldn't weigh yourself2:58 Hormones and weight loss8:12 Sleep and weight loss 11:22 Healthy weight-loss tips 16:36 The best weight-loss advice Scale obsession is not helpful for weight loss. The rise in cortisol from scale anxiety alone is enough to stifle your progress! Here are 11 reasons why you shouldn't weigh yourself: 1. Water weightSome people can lose up to 11 pounds of water weight in just 2 days! Initial water weight loss can cause unrealistic expectations. Most people only lose 1 to 2 pounds per week. 2. Salt Salty foods can cause you to retain fluid, especially if you're consuming them with sugar. 3. HormonesA woman's menstrual cycle can often cause weight-loss fluctuations of around 3 to 7 pounds. A rise in cortisol can also prevent weight loss. 4. Location of fatThe worst type of fat is visceral fat, which accumulates around the organs. If you don't see weight loss right away, you could be losing some of the more dangerous types of fat first. 5. Muscle loss or gainLosing muscle isn't healthy! Your weight may be decreasing, but it could also be accompanied by serious side effects. Similarly, muscle weighs more than fat, so you won't see weight loss if you're building muscle. 6. Myxedema This type of fat is often found in people with hypothyroidism and is difficult to eliminate with diet and exercise alone. 7. Poor sleepOne week of poor sleep can increase insulin resistance! Poor sleep leads to snacking, increased visceral fat, lower testosterone levels, and higher cortisol and stress levels.8. Ozempic People lose weight with Ozempic, but typically regain it when they discontinue use. Around 20% to 40% of this weight loss is attributed to muscle loss.9. Microdamage from exercise Overtraining breaks down your muscles. Edema and swelling can cause your weight to increase after exercise. 10. MedicationMedications such as calcium channel blockers can cause weight gain. 11. ConstipationFiber intake and constipation can affect the number on the scale. Stop weighing yourself and focus on these healthy weight-loss tips instead:1. Waist-to-height ratio 2. Fasting insulin3. Appetite decreases 4. Tiny amounts of carbs can block fat burning5. Fix insulin resistanceInsulin resistance is the root cause of many chronic diseases. Fixing it is the key to getting healthy and losing weight. Dr. Eric Berg DC Bio:Dr. Berg, age 60, is a chiropractor who specializes in Healthy Ketosis & Intermittent Fasting. He is the Director of Dr. Berg Nutritionals and author of the best-selling book The Healthy Keto Plan. He no longer practices, but focuses on health education through social media.Disclaimer: Dr. Eric Berg received his Doctor of Chiropractic degree from Palmer College of Chiropractic in 1988. His use of “doctor” or “Dr.” in relation to himself solely refers to that degree. Dr. Berg is a licensed chiropractor in Virginia, California, and Louisiana, but he no longer practices chiropractic in any state and does not see patients, so he can focus on educating people as a full-time activity, yet he maintains an active license. This video is for general informational purposes only. It should not be used to self-diagnose, and it is not a substitute for a medical exam, cure, treatment, diagnosis, prescription, or recommendation. It does not create a doctor-patient relationship between Dr. Berg and you. You should not make any change in your health regimen or diet before first consulting a physician and obtaining a medical exam, diagnosis, and recommendation. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition.

Markets are printing fresh highs, yet some investors are getting crushed—how does that happen? In this roundtable, Ryan Payne, Bob Payne, Courtney Garcia, and Frankie Lagrotteria break down a real case of a couple in their late 50s whose “do‑anything‑to-go-faster” portfolio relied on leverage and crowd‑favorite names…right as they approach full retirement. We dissect why speculation masquerading as strategy can implode even in up markets, why “know what you own and why you own it” matters more than ever, and how to rebuild a plan centered on durable income and disciplined risk management. You'll hear why the “Ozempic portfolio” analogy fits—everyone wants the quick fix—but lasting wealth still requires basics: diversified exposure, sensible cash flow, and rules that keep emotions out of the driver's seat. We also cover today's opportunities to generate income (value, small caps, international, REITs, and bonds at still‑elevated yields), our 5% rebalance discipline, and the investor psychology traps that move the goalposts until a margin call makes the decision for you. As Bob puts it: time passes, markets operate—embrace that principle, and you'll stop chasing the cool kids and start compounding with the rich ones. What we cover: Why leverage is a “rocket booster” on both gains and losses—and how portfolios can sink while indexes rise The danger of fashion FOMO: copying friends, gym talk, or headlines instead of a plan Income blindness: several million invested but only ~$4K/year in cash flow—why that's a retirement red flag Today's income playbook: value, small caps, international, REITs, and bonds (with yields still attractive) Discipline over drama: our 5% rebalance trigger and rules that keep feelings from running your money Investor psychology: goalpost‑moving, “being right twice” in speculation, and volatility as the fee for long‑term returns Practical steps to audit and de‑risk before retirement Key takeaways: Know what you own and why. Double‑levered bets can fall even when the market is up—understand the mechanics before you buy. Build real cash flow. Retirement works best when your portfolio pays you, so diversify toward durable income sources. Write your rules. Pre‑commit to rebalance triggers, position limits, and exit criteria to avoid emotional decisions. Approximately right beats precisely wrong. You don't need to predict the next macro move; you need a plan you can stick to. Calls to action: If you're within 5–10 years of retirement, run a leverage and income audit on your portfolio. Want help building a rules‑based, income‑focused plan? Schedule a consult with the Payne Capital team and let's put discipline to work: paynecm.com/financialplan/ — Enjoying the show? Follow, rate, and review Payne Points of Wealth on Apple Podcasts and Spotify and share this episode with a friend who's chasing “quick wins” instead of compounding.

Fashion writer Amy Larocca joins Vanessa to unpack the modern wellness obsession—from expensive self-care gadgets to Ozempic and glow culture. They dig into Amy's book How to Be Well: Navigating Our Self-Care Epidemic, One Dubious Cure at a Time and ask when wellness became a moral obligation. Click ‘Subscribe' at the top of the Infamous show page on Apple Podcasts or visit GetTheBinge.com to get access wherever you get your podcasts. Find more great podcasts from Sony Music Entertainment at sonymusic.com/podcasts  Read Vanessa's book, Blurred Lines: Sex, Power and Consent on Campus, and check out Natalie on Instagram at @natrobe To connect with Infamous's creative team, join the community at joincampsidemedia.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

durée : 00:02:54 - L'Humeur du matin par Guillaume Erner - par : Guillaume Erner - Je suis resté songeur devant cette couverture de L'Express. La millième, sans doute, consacrée aux médicaments du XXIᵉ siècle : Ozempic, Mounjaro, et toute cette pharmacopée miracle censée nous faire fondre. - réalisation : Félicie Faugère

On this, our 305th Evolutionary Lens livestream, we discuss evolution, including major transitions from sea to land (early amphibians), and back again (e.g. whales), and the evidence. Where should we expect gaps in the fossil record, and why? How are adaptations to space and time analogous to one another? Then: lab grown pig fat is combined with plant protein and turned into meatballs that pretend to be pork. What could go wrong? Prediction: they'll be carcinogenic. Finally: GLP-1s—e.g. Ozempic—have so many side effects. Now on people's radar: they decrease drive and pleasure in all things, including libido.*****Our sponsors:Everyday Dose: Coffee plus collagen, mushrooms & nootropics – delicious! Get 45% off your first subscription order and also receive free gifts at  http://everydaydose.com/darkhorse.CrowdHealth: Pay for healthcare with crowdfunding instead of insurance. It's way better. Use code DarkHorse at http://JoinCrowdHealth.com to get 1st 3 months for $99/month.ARMRA: Colostrum is our first food, and can help restore your health and resilience as an adult. Go to http://www.tryarmra.com/DARKHORSE to get 15% off your first order.*****Join us on Locals! Get access to our Discord server, exclusive live streams, live chats for all streams, and early access to many podcasts: https://darkhorse.locals.comHeather's newsletter, Natural Selections (subscribe to get free weekly essays in your inbox): https://naturalselections.substack.comOur book, A Hunter-Gatherer's Guide to the 21st Century, is available everywhere books are sold, including from Amazon: https://amzn.to/3AGANGg (commission earned)Check out our store! Epic tabby, digital book burning, saddle up the dire wolves, and more: https://darkhorsestore.org*****Mentioned in this episode:Jim Tour, physicist, talking to Tucker Carlson about creationism: https://x.com/uncommonsince76/status/2000981781651009727Bret's dissertation: https://backend.production.deepblue-documents.lib.umich.edu/server/api/core/bitstreams/0617b499-b8e8-4071-9a21-95f4c39f8372/contentBacon that isn't bacon: https://grist.org/climate-energy/this-pigs-bacon-was-delicious-but-shes-alive-and-well/Pharma Darlings: https://naturalselections.substack.com/p/pharma-darlingsGLP-1s flatten sex drive: https://www.thecut.com/article/glp-1-weight-loss-drugs-ozempic-sex-drive-side-effects.htmlSupport the show

331: What do Ozempic, Hashimoto's, hormone issues, and our digestion all have in common?Today you're going to get the answer as McCall McPherson joins me in a conversation all about the thyroid, what hypothyroidism and hyperthyroidism are, and how it's all connected to our weight, digestion, hormones, and so much more. McCall shares her research on how microdosing Ozempic can help with thyroid issues within just weeks, without the side effects. As you know, I am not a fan of Ozempic, so I asked McCall to convince me to change my mind…and I can't wait for you to hear what happened! Topics Discussed:→ What the thyroid does for the body→ Types of thyroid issues→ Symptoms to look for if you have thyroid issues→ Ways to prevent thyroid issues→ Natural remedies to support the thyroid→ Thyroid issues in kids→ Ozempic—how it can help→ How to test and what to look for on a thyroid test→ Foods to avoid for thyroid issues→ Where to seek help As always, if you have any questions for the show please email us at digestthispod@gmail.com. And if you like this show, please share it, rate it, review it and subscribe to it on your favorite podcast app.  Sponsored By:  → Fatty15 | For 15% off the starter kit go to https://fatty15.com/digest → Manukora | Head to https://manukora.com/DIGEST to get $70 off the Starter Kit → Pique Life | https://piquelife.com/digest for up to 20% OFF and a free starter kit → Bethany's Pantry | Go to https://bethanyspantry.com/ and use code PODCAST10 for $10 anything! Check Out McCall McPherson: → Website → Instagram → TikTok → Thyroid Chart → Podcast  Check Out Bethany: → Bethany's Instagram: @lilsipper → YouTube → Bethany's Website → Discounts & My Favorite Products → My Digestive Support Protein Powder → Gut Reset Book  → Get my Newsletters (Friday Finds) Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Mike explains why calories in vs calories out is a bit more nuanced than many people make it seem. Also, are all calories created equal? Is it truly just a numbers game? Tune in for a complete breakdown of what really matters when it comes to nutrition and calories.------------------------------------------------Click here to apply for coaching!For some amazing resources and to be a part of a badass community, join our FB group HEREThe personality assessment is now available online! Click here to take the assessment and find out what your personality tells us about the way you should be training and eating.Take the assessment here!To learn more about Neurotyping, visit www.neurotypetraining.comFollow Mike on IG at @coach_mike_millner

(December 17, 2025) Warner Bros. rejects Paramount’s hostile bid, accusing Ellison Family of failing to put money into the deal. Why Made in the USA doesn’t appear on artificial Christmas trees. Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany talks with Bill about poor sleep triggering a vicious cycle your brain can’t break, Psilocybin breaking depressive cycles by rewiring the brain, and a weight loss strategy that is 5x more effective than Ozempic.See omnystudio.com/listener for privacy information.

GLP-1 drugs like Ozempic, Wegovy, and Zepbound are changing medicine — but at what cost? In this episode of The Exam Room Podcast, host Chuck Carroll sits down with Ben Urich, PharmD, PhD, to break down the real-world data behind the GLP-1 explosion. You'll learn: - How many people are actually using GLP-1 drugs - Why most users stop — and why that's starting to change - The true cost of GLP-1 medications to employers and health plans - Common and serious side effects to be aware of - Why GLP-1s are now being studied for Alzheimer's disease and addiction - What the future holds as more than 30 new drugs enter the pipeline This is a must-watch conversation for anyone considering GLP-1 medications, currently using Ozempic or Wegovy, or wondering where modern weight-loss medicine is headed next.

In this episode, I reconnect with my friend, fitness expert, and midlife wellness coach, Natalie Jill. The last time we had a conversation on the show was eight years ago, and a lot has changed since then. Natalie has not only evolved her brand, but she has completely transformed the way she approaches health, aging, performance, and mindset. This is a powerful and honest conversation about what it really means to live a healthy life at any age, especially through midlife. Natalie shares how she shifted from being known for general fitness and fat loss to becoming a leading voice in midlife wellness, hormone health, and aging with intention. We talk about what sparked that transition, how she redefined her mission, and why being deeply interested in your work is the key to any sustainable transformation. She opens up about navigating the overwhelming amount of information in the health space, and how midlife can be a confusing season where symptoms change, metabolism shifts, and the old tools don't always work anymore. We dive into biohacking, natural wellness, supplements, and the role of personalized nutrition. Natalie explains why you have to become your own health detective and why cookie-cutter fitness programs often fail women and men navigating midlife. We also get into the complexities of hormone replacement therapy, how to think through GLP-1 medications, and why sleep might be the most underrated performance enhancer of all. One of the things I've always admired about Natalie is her ability to evolve and reinvent herself without losing authenticity. We discuss the pressure of showing up online, the struggle to post consistently, controversial content, and how to stay aligned with your mission even when the internet has its own opinions. This is an empowering, honest, and deeply practical conversation for anyone looking to take ownership of their health, find passion in their work again, and embrace midlife with clarity and confidence. In This Episode, You'll Learn: How Natalie Jill reinvented her brand and why midlife wellness became her mission Why midlife requires new strategies for nutrition, metabolism, and fitness How to cut through the noise in the health and wellness industry The role of biohacking and simple daily habits that actually make a difference Sleep strategies that improve energy, recovery, and overall health The truth about GLP-1 medications like Ozempic and who they are really for What most people misunderstand about hormone replacement therapy How to stay authentic and consistent in content creation Why passion, curiosity, and reinvention are essential at every stage of life How to approach midlife with empowerment instead of fear

What No One Tells You About Life After GLP-1 Meds GLP-1 medications like Ozempic, Wegovy, and Mounjaro have changed the game for weight loss—but what happens when the prescription ends and you need a plan? This week, I'm joined by Dr. Jim Hill, leading obesity researcher and architect of the National Weight Control Registry, to uncover what really happens after GLP-1s—and how to maintain your results without spiraling into regain. We'll explore the three types of weight regain, what makes maintenance so different from weight loss, and why your body is capable of mimicking GLP-1 effects naturally—if you know how to support it. Whether you're on these meds now, thinking of stopping, or just want to protect your progress, this is a must-listen.

Detroit Lions lose to the LA Rams, Sherrone Moore fallout, Eli Zaret joins us, Taylor Swift makes everyone cry, Jeffrey Epstein's photos, Meghan Markle steals a documentary, and reviewing John Wayne Bobbitt's acting. Eli Zaret joins the show to overreact to the Lions 41-34 loss to the LA Rams, the return of grandpa Philip Rivers to the Indianapolis Colts, Bijan Robinson's homophobic flub, Todd Bowels drops some expletives after Tampa Bay lost, the epic collapse of Sherrone Moore, his OnlyFans hussy, Warde Manuel's future, the next head coach of the cult, Dusty May's hot start with the Wolverines, Jake Paul vs Anthony Joshua and more. Death: RIP Pulp Fiction's Peter Greene. RIP Pauline Potter of My 600-LB Life. Movies: Marc and Drew caught the Spinal Tap II on HBO… and highly recommend it.Drew watched Jay Kelly starring George Clooney and Adam Sandler for 2 hours and 18 minutes. Fun fact: Adam Sandler and Stuttering John are Eskimo brothers. Taylor Swift is emotional in clips from her new docuseries. It also features a lot of dudes crying. Robotic Fernando Mendoza put on quite a speech after winning the Heisman Trophy. Tashella Sheri Amore Dickerson is busted with some BLM fraud. Did Ilhan Omar marry her brother or what? Missing Virginia High School football coach Travis Turner is nowhere to be found. Hot Judge Tiffany Foxworth-Roberts is BLOWN OUT due to stolen valor. Charlie Kirk killer, Tyler Robinson, appeared in court. A new treasure trove of Jeffrey Epstein files and photos were dumped. He was pretty tight with Steve Bannon. We watch the incredible acting of John Wayne Bobbitt (NSFW). Looks: La Toya Jackson is sparking concern. Skinny Amy Schumer dumps her husband. Ozempic is making people look weird. Mike & Molly star Billy Gardell looks unrecognizable. Oprah Winfrey thinks she's hot now. Hey Carrie Underwood, why you look different? Eminem wanted Kate Winslet to shave his butt. Meghan Markle continues to struggle to reach her father. The beast is blaming The Daily Mail and their kindness to Thomas. Meghan has a documentary on Girl Scout Cookies coming out. She had nothing to do with the making of the doc and nobody will watch. Better hurry up and get your merch before the molds are broken. If you'd like to help support the show… consider subscribing to our YouTube Channel, Facebook, Instagram and Twitter (Drew Lane, Marc Fellhauer, Trudi Daniels, Jim Bentley and BranDon).

Dr. Dubrow names the GLP-1 that will take over 2026. Meanwhile, Heather takes a ‘jab’ at post-Ozempic beauty standards, and who is Terry telling to STFU?See omnystudio.com/listener for privacy information.

Episode 2704 - In this health-supplementation focused episode, Ted and Austin Broer examine Adderall adrenal impacts while addressing Ozempic pharmaceutical risks and natural sleep protocol alternatives. The show opens with Adderall adrenal fatigue examination revealing long-term amphetamine use causing extreme exhaustion requiring adrenal support supplementation and stimulant breaks achieving homeostasis preventing cortisol acceleration aging. Natural sleep protocol promotion highlights Total Rest, Magnesium Brain Food, and Melatonin combination as pharmaceutical alternative avoiding NyQuil addiction and long-term health risks with customer testimonials. Ozempic side effect warnings address stomach paralysis, intestinal blockages, and vision loss requiring dietary changes for sustainable weight management through small frequent meals and nutrient-dense organic foods. Supplement absorption guidance covers plant cellulose capsule rapid dissolution requiring food consumption for efficient digestion and nutrient uptake avoiding water-only intake inefficiency. Germany Christmas market cancellation discusses Angela Merkel immigration policy consequences creating security cost burdens from terrorist attack protection concerns affecting cultural traditions.

Tim discusses Erika Kirk's upcoming CBS News town hall with Bari Weiss, the Paramount versus Netflix bidding war for Warner Bros., Bonnie Blue being detained in Bali for a "bang bus" stunt, how to enjoy Christmas on Ozempic, the “swag gap” in Gen Z dating, Somalis in Minnesota, and Italian brainrot. American Royalty Tour